| 000 | 01432 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513213640.0 | ||
| 264 | 0 | _c20000828 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/315661 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeumann, A U | |
| 245 | 0 | 0 |
_aDifferences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cJul 2000 |
||
| 300 |
_a28-35 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aRNA, Viral _xmetabolism |
| 700 | 1 | _aLam, N P | |
| 700 | 1 | _aDahari, H | |
| 700 | 1 | _aDavidian, M | |
| 700 | 1 | _aWiley, T E | |
| 700 | 1 | _aMika, B P | |
| 700 | 1 | _aPerelson, A S | |
| 700 | 1 | _aLayden, T J | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 182 _gno. 1 _gp. 28-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/315661 _zAvailable from publisher's website |
| 999 |
_c10833125 _d10833125 |
||